EG
Ekkehard Grunig
Elite in Telangiectasia

Ekkehard Grunig

Thoraxklinik-Heidelberg, Zentrum Für Pulmonale Hypertonie
Germany
Elite
 in Telangiectasia
Clinical Trials:Currently Recruiting for 10 Trials
About|Expertise|Location|Research
Areas of Expertise

Many experts have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a expert treats and their level of experience.

Check Ekkehard Grunig's experience treating your condition:
About Ekkehard Grunig

Ekkehard Grunig practices in Heidelberg, Germany. Grunig is rated as an Elite expert by MediFind in the treatment of Telangiectasia. They are also highly rated in 13 other conditions, according to our data. Their top areas of expertise are Pulmonary Hypertension, Hypertension, Telangiectasia, Lung Transplant, and Heart Transplant.

Their clinical research consists of co-authoring 217 peer reviewed articles and participating in 26 clinical trials in the past 15 years. In particular, they have co-authored 25 articles and participated in 13 clinical trials in the study of Telangiectasia.

Locations
Heidelberg, 69126, DE
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

26 Clinical Trials
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Recruiting
Publish Date: October 03, 2022
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
Influence of Breath- and Movementtherapy to Clinical and Molecular Parameter in Patients With Pulmonary Hypertension
Enrollment Status: Recruiting
Publish Date: July 14, 2022
Intervention Type: Other
Study Phase: Not Applicable
Effect of Exercise and Respiratory Therapy on Right Ventricular Function in Severe Pulmonary Hypertension
Enrollment Status: Recruiting
Publish Date: July 14, 2022
Intervention Type: Other
Study Phase: Not Applicable
Exercise and Respiratory Therapy in Patients With Rheumatoid Arthritis / Collagenosis and Pulmonary Hypertension
Enrollment Status: Recruiting
Publish Date: July 14, 2022
Intervention Type: Behavioral
Study Phase: Not Applicable
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy in Newly Diagnosed Intermediate- and High-risk PAH Patients
Enrollment Status: Recruiting
Publish Date: December 06, 2022
Intervention Type: Other, Drug
Study Drug: Sotatercept
Study Phase: Phase 3
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by CPET in Subjects With WHO Group 1 Pulmonary Hypertension Who Recently Initiated Therapy
Enrollment Status: Recruiting
Publish Date: July 20, 2022
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
Prospective, Randomized, Controlled Trial of the Effect of Long-term Oxygen Therapy on 6-minute Walking Distance, Clinical Parameters and Hemodynamics in Patients With PAH and CTEPH
Enrollment Status: Recruiting
Publish Date: July 14, 2022
Intervention Type: Drug
Study Drug: Oxygen
Study Phase: Phase 2
An Open-label, Prospective, Single Centre Study of the Effects of Riociguat on RIght VEntricular Size and Function in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
Enrollment Status: Recruiting
Publish Date: April 22, 2022
Intervention Type: Drug
Study Drug: Riociguat
Study Phase: Phase 4
Incidence of Latent Pulmonary Hypertension in Patients With Chronic Thromboembolic Pulmonary Hypertension After Endarterectomy and Influence of Exercise and Respiratory Therapy
Enrollment Status: Recruiting
Publish Date: July 14, 2022
Intervention Type: Behavioral, Other
Study Phase: Not Applicable
Influence of Respiratory and Exercise Therapy on Oxygen Uptake, Quality of Life in Patients With Severe Associated Pulmonary Arterial Hypertension (APAH) as Part of a Congenital Heart Defect With / Without Eisenmenger's Syndrome
Enrollment Status: Recruiting
Publish Date: July 14, 2022
Intervention Type: Other
Study Phase: Not Applicable
Association Between BMPR2 Mutations and Iron Metabolism in Pulmonary Arterial Hypertension Patients: an Explorative Cross-sectional Study
Enrollment Status: Completed
Publish Date: April 29, 2021
Intervention Type: Diagnostic Test
Implementation and Effect of Exercise and Respiratory Training on 6-minute Walking Distance in Patients With Severe Chronic Pulmonary Hypertension: a Randomized Controlled Multicenter Trial in European Countries
Enrollment Status: Completed
Publish Date: December 19, 2019
Intervention Type: Other
Study Phase: Not Applicable
Efficacy and Safety of Riociguat (MK-4836) in Incipient Pulmonary Vascular Disease as an Indicator for Early Pulmonary Arterial Hypertension Double-blind, Randomized, Multicenter, Multinational, Placebo-controlled Phase IIa Study (ESRA)
Enrollment Status: Not yet recruiting
Publish Date: July 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 2
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH
Enrollment Status: Completed
Publish Date: December 15, 2022
Intervention Type: Drug
Study Drug: Sotatercept
Study Phase: Phase 3
A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Enrollment Status: Completed
Publish Date: February 13, 2020
Intervention Type: Drug
Study Phase: Phase 3
Susceptibility to High Altitude Pulmonary Edema in Subjects With Increased Pulmonary Artery Pressure During Exercise in Normoxia and at Rest in Hypoxia
Enrollment Status: Completed
Publish Date: September 06, 2013
Intervention Type: Other
Study Phase: Not Applicable
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: May 03, 2021
Intervention Type: Drug
Study Phase: Phase 3
Early Treatment of Borderline Pulmonary Arterial Hypertension Associated With Systemic Sclerosis (SSc-APAH) A Randomized, Controlled, Double-blind, Parallel Group, Proof-of-concept Trial EDITA
Enrollment Status: Completed
Publish Date: April 30, 2020
Intervention Type: Drug
Study Phase: Phase 2
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Terminated
Publish Date: March 24, 2022
Intervention Type: Drug
Study Phase: Phase 3
Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310
Enrollment Status: Completed
Publish Date: June 02, 2022
Intervention Type: Drug
Study Drug: UT-15C
Study Phase: Phase 3
Effect of Pharmacologic Interaction Between Endothelin-Receptor-Antagonists and Phosphodiesterase-5 Inhibitors on Medication Serum Levels and Clinical Disease Status in Patients Wih Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: February 05, 2020
Intervention Type: Other
A Clinical Proof of Concept Study of IMMUNOadsorption Therapy in Patients With Idiopathic Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: July 10, 2020
Intervention Type: Device
Study Phase: Not Applicable
Feasibility and Influence of Respiratory and Exercise Therapy on Oxygen Uptake, Quality of Life and Right Heart Function in Chronic Thromboembolic Pulmonary Hypertension After Thromboendarterectomy
Enrollment Status: Completed
Publish Date: May 10, 2021
Intervention Type: Behavioral
Study Phase: Not Applicable
Study of Influence of Respiratory and Exercise Therapy on Oxygen Uptake, Quality of Life and Right Ventricular Function in Severe Pulmonary Hypertension
Enrollment Status: Completed
Publish Date: December 23, 2019
Intervention Type: Other
Study Phase: Not Applicable
Implementation, Safety, Tolerability and Effect of Exercise and Respiratory Training on 6-minute Walking Distance in Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (HFpEF): a Randomized Controlled Multicenter Trial in European Countries.
Enrollment Status: Not yet recruiting
Publish Date: September 16, 2022
Intervention Type: Other
Study Phase: Not Applicable
Iloprost for Bridging to Heart Transplantation in Patients With Pulmonary Hypertension and Left Heart Failure A Randomized, Controlled, Double-blind, Parallel Group, Proof-of-concept Trial
Enrollment Status: Withdrawn
Publish Date: December 23, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 16 Less Clinical Trials -
217 Total Publications
Genetic counselling and testing in pulmonary arterial hypertension -A consensus statement on behalf of the International Consortium for Genetic Studies in PAH.
Journal: The European respiratory journal
Published: July 22, 2022
Save this expert for later
Sign Up
Looking for the best expert for you?
Start Here
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more